Are you over 18 and want to see adult content?
More Annotations
A complete backup of revolutionise.sg
Are you over 18 and want to see adult content?
A complete backup of daddyloops.tumblr.com
Are you over 18 and want to see adult content?
A complete backup of 777planetmen.tumblr.com
Are you over 18 and want to see adult content?
A complete backup of hallensteins.com
Are you over 18 and want to see adult content?
A complete backup of citypulsecolumbus.com
Are you over 18 and want to see adult content?
A complete backup of licorn1994.tumblr.com
Are you over 18 and want to see adult content?
Favourite Annotations
A complete backup of goodnightlamp.com
Are you over 18 and want to see adult content?
A complete backup of ratemyserver.net
Are you over 18 and want to see adult content?
A complete backup of linncountyfire.net
Are you over 18 and want to see adult content?
A complete backup of mysticboarding.com
Are you over 18 and want to see adult content?
A complete backup of malwarehunterteam.com
Are you over 18 and want to see adult content?
A complete backup of crossed-flag-pins.com
Are you over 18 and want to see adult content?
Text
ALCON: CAREERS
Alcon is an Equal Opportunity Employer and participates in E-Verify. Alcon takes pride in maintaining a diverse environment and our policies are not to discriminate in recruitment, hiring, training, promotion or other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, gender identity, marital or veteran status, disability, or any other ALCON - NEWS AND EVENTS - EVENTS & PRESENTATIONS Alcon’s Fourth Quarter and Full Year 2020 Earnings Conference Call. Webcast (opens in new window) Earnings Release (opens in new window) Form 20-F (opens in new window) Regulatory Filing (opens in new window) Presentation (opens in new window) 01/12/2021 02:00 PM ET. 39th Annual JP Morgan Healthcare Conference. Webcast (opens in newwindow)
ALCON
Convert K-readings to initial recommendation for our soft lensproducts. Content:
ALCON ANNOUNCES ACQUISITION OF POWERVISION, INC. Fort Worth, Texas, March 18, 2019 – Alcon, the global leader in eye care and a division of Novartis, announced today that it has acquired PowerVision, Inc., a privately-held, US-based medical device development company focused on creating fluid-based intraocular lens implants. The acquisition furthers Alcon’s commitment to bring this innovative, accommodating lens to cataract patients ALCON - FINANCIALS - ANNUAL REPORTS Alcon is incorporated outside the U.S. and qualifies as a foreign private issuer, or FPI. As long as we qualify as an FPI, we will be exempt from certain provisions of the Securities Exchange Act of 1934 that are applicable to U.S. domestic public companies, including: regulations governing the solicitation of proxies; consents or authorizations in respect of registered securities ALCON INTRODUCES NEWLY OPTIMIZED ULTRASERT® PRE-LOADED NEW ORLEANS, November 9, 2017 – Alcon, the global leader in eye care and a division of Novartis, will introduce the newly optimized UltraSert® delivery system pre-loaded with the AcrySof® IQ aspheric monofocal intraocular lens (IOL) for people undergoing cataract surgery at the 2017 American Academy of Ophthalmology (AAO) annual meeting, taking place November 11 – 14 in New Orleans. ALCON - ALCON FILES FINAL 20F To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address.HOME | AU.ALCON.COM
See Brilliantly. We aspire to lead the world in innovating life-changing vision and eye care products because when people see brilliantly, they live brilliantly. lightshow. About Alcon. Careers. Corporate Responsibility. Please wait for your event to start. The event has now ended. 0:00 | 1:27 LIVE. ALCON OFFICIAL SITE: DEVELOPING INNOVATIVE EYE CAREINNOVATIONCONTACT USCAREER SEARCHABOUT USINVESTOR RELATIONSMEDIA RELEASES At Alcon, we are proudly committed to creating a work culture that welcomes and celebrates diversity and inclusion. That’s why we are thrilled Alcon has earned a 95 percent rating on the Human Rights Campaign’s 2021 Corporate Equality Index.. Now in its 19th year, the Human Rights Campaign’s annual survey examines corporate policies and practices related to workplace equality for lesbian NEW ALCON DATA ON CONTACT LENS, DRY EYE AND OCULAR HEALTH Alcon, the global leader in eye care, will present new data on several of its latest contact lens, dry eye and ocular health innovations during the Association for Research in Vision and Ophthalmology (ARVO) 2021 virtual meeting taking place May 1-7. Alcon boasts a robust scientific showing at the meeting with nine accepted abstracts on vision care innovations including theALCON: CAREERS
Alcon is an Equal Opportunity Employer and participates in E-Verify. Alcon takes pride in maintaining a diverse environment and our policies are not to discriminate in recruitment, hiring, training, promotion or other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, gender identity, marital or veteran status, disability, or any other ALCON - NEWS AND EVENTS - EVENTS & PRESENTATIONS Alcon’s Fourth Quarter and Full Year 2020 Earnings Conference Call. Webcast (opens in new window) Earnings Release (opens in new window) Form 20-F (opens in new window) Regulatory Filing (opens in new window) Presentation (opens in new window) 01/12/2021 02:00 PM ET. 39th Annual JP Morgan Healthcare Conference. Webcast (opens in newwindow)
ALCON
Convert K-readings to initial recommendation for our soft lensproducts. Content:
ALCON ANNOUNCES ACQUISITION OF POWERVISION, INC. Fort Worth, Texas, March 18, 2019 – Alcon, the global leader in eye care and a division of Novartis, announced today that it has acquired PowerVision, Inc., a privately-held, US-based medical device development company focused on creating fluid-based intraocular lens implants. The acquisition furthers Alcon’s commitment to bring this innovative, accommodating lens to cataract patients ALCON - FINANCIALS - ANNUAL REPORTS Alcon is incorporated outside the U.S. and qualifies as a foreign private issuer, or FPI. As long as we qualify as an FPI, we will be exempt from certain provisions of the Securities Exchange Act of 1934 that are applicable to U.S. domestic public companies, including: regulations governing the solicitation of proxies; consents or authorizations in respect of registered securities ALCON INTRODUCES NEWLY OPTIMIZED ULTRASERT® PRE-LOADED NEW ORLEANS, November 9, 2017 – Alcon, the global leader in eye care and a division of Novartis, will introduce the newly optimized UltraSert® delivery system pre-loaded with the AcrySof® IQ aspheric monofocal intraocular lens (IOL) for people undergoing cataract surgery at the 2017 American Academy of Ophthalmology (AAO) annual meeting, taking place November 11 – 14 in New Orleans. ALCON - ALCON FILES FINAL 20F To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address.HOME | AU.ALCON.COM
See Brilliantly. We aspire to lead the world in innovating life-changing vision and eye care products because when people see brilliantly, they live brilliantly. lightshow. About Alcon. Careers. Corporate Responsibility. Please wait for your event to start. The event has now ended. 0:00 | 1:27 LIVE. NEW ALCON DATA ON CONTACT LENS, DRY EYE AND OCULAR HEALTH Alcon, the global leader in eye care, will present new data on several of its latest contact lens, dry eye and ocular health innovations during the Association for Research in Vision and Ophthalmology (ARVO) 2021 virtual meeting taking place May 1-7. Alcon boasts a robust scientific showing at the meeting with nine accepted abstracts on vision care innovations including the ALCON TO SHOWCASE VISION CARE INNOVATION, INCLUDING .q4default .bwlistdecimal { list-style-type: decimal }.q4default .bwlistdisc { list-style-type: disc }.q4default .bwuline { text-decoration: underline } 18 abstracts accepted, underscoring Alcon’s commitment to vision, comfort and ocular surface health TOTAL30 designed with water gradient technology that has biomimetic properties that mimic the corneal surface and demonstratesALCON PATENT LIST
The following products are protected by U.S. patents as indicated below. This website is provided to satisfy the virtual patent marking provisions of the America Invents Act under 35 U.S.C. § 287(a). The following list of products may not be all inclusive, and other products not listed here may be protected by one or more patents. ALCON INTRODUCES SYSTANE® HYDRATION PRESERVATIVE-FREE March 5, 2020 Alcon, the global leader in eye care and Official Sponsor of 20/20™, today introduced SYSTANE® HYDRATION Preservative-Free (PF), the latest addition to the #1 doctor recommended SYSTANE Family of Products, at the SECO International 2020 meeting (#SECO2020). SYSTANE HYDRATION PF Lubricant Eye Drops is a new preservative-free option for dry eye sufferers CORPORATE SOCIAL RESPONSIBILITY Corporate Responsibility Report. Alcon has been actively engaged in environmental, social and governance (ESG) initiatives during our 70+ years in ophthalmology and optometry. In publishing our first Corporate Responsibility Report as an independent, standalone company, we are sharing our perspective on corporate citizenship anddemonstrating
ALCON - NEWS AND EVENTS - EVENTS & PRESENTATIONS Alcon’s Fourth Quarter and Full Year 2020 Earnings Conference Call. Webcast (opens in new window) Earnings Release (opens in new window) Form 20-F (opens in new window) Regulatory Filing (opens in new window) Presentation (opens in new window) 01/12/2021 02:00 PM ET. 39th Annual JP Morgan Healthcare Conference. Webcast (opens in newwindow)
ALCON ANNOUNCES LAUNCH OF ACRYSOF IQ VIVITY, THE FIRST AND Vivity is a first-of-its-kind, non-diffractive extended depth of focus IOL with Alcon’s proprietary non-diffractive X-WAVE™ technology, which stretches and shifts light without splitting it. 1 Vivity delivers monofocal-quality distance (far) with excellent intermediate (at arm’s length) and functional near vision (up close). *2 The lens expands Alcon’s growing portfolio of presbyopia ALCON FEATURES NEW TECHNOLOGY UPGRADES FOR THE ORA SYSTEM San Diego, California, April 14, 2015 – Alcon, the global leader in eye care, will introduce enhancements to both the ORA System ® and the VERION™ Image Guided System, providing improved capabilities and efficiency during both preoperative planning and intraoperative guidance during the cataract surgery procedure. The new VerifEye+™ Technology and VERION 2.6 software update will be ALCON INTRODUCES NEWLY OPTIMIZED ULTRASERT® PRE-LOADED NEW ORLEANS, November 9, 2017 – Alcon, the global leader in eye care and a division of Novartis, will introduce the newly optimized UltraSert® delivery system pre-loaded with the AcrySof® IQ aspheric monofocal intraocular lens (IOL) for people undergoing cataract surgery at the 2017 American Academy of Ophthalmology (AAO) annual meeting, taking place November 11 – 14 in New Orleans. HOME | ALCON.COMTRANSLATE THIS PAGE Wie optimaal ziet, leeft optimaal. Daarom streeft Alcon er elke dag naar om wereldleider te zijn in het bieden van optimale ooggezondheid en innoverende oogzorgproducten. lightshow. Over Alcon. Carrière bijAlcon.
ALCON OFFICIAL SITE: DEVELOPING INNOVATIVE EYE CAREINNOVATIONCONTACT USCAREER SEARCHABOUT USINVESTOR RELATIONSMEDIA RELEASES At Alcon, we are proudly committed to creating a work culture that welcomes and celebrates diversity and inclusion. That’s why we are thrilled Alcon has earned a 95 percent rating on the Human Rights Campaign’s 2021 Corporate Equality Index.. Now in its 19th year, the Human Rights Campaign’s annual survey examines corporate policies and practices related to workplace equality for lesbian NEW ALCON DATA ON CONTACT LENS, DRY EYE AND OCULAR HEALTH Alcon, the global leader in eye care, will present new data on several of its latest contact lens, dry eye and ocular health innovations during the Association for Research in Vision and Ophthalmology (ARVO) 2021 virtual meeting taking place May 1-7. Alcon boasts a robust scientific showing at the meeting with nine accepted abstracts on vision care innovations including theALCON: CAREERS
Alcon is an Equal Opportunity Employer and participates in E-Verify. Alcon takes pride in maintaining a diverse environment and our policies are not to discriminate in recruitment, hiring, training, promotion or other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, gender identity, marital or veteran status, disability, or any other ALCON - NEWS AND EVENTS - EVENTS & PRESENTATIONS Alcon’s Fourth Quarter and Full Year 2020 Earnings Conference Call. Webcast (opens in new window) Earnings Release (opens in new window) Form 20-F (opens in new window) Regulatory Filing (opens in new window) Presentation (opens in new window) 01/12/2021 02:00 PM ET. 39th Annual JP Morgan Healthcare Conference. Webcast (opens in newwindow)
ALCON
Convert K-readings to initial recommendation for our soft lensproducts. Content:
ALCON ANNOUNCES ACQUISITION OF POWERVISION, INC. Fort Worth, Texas, March 18, 2019 – Alcon, the global leader in eye care and a division of Novartis, announced today that it has acquired PowerVision, Inc., a privately-held, US-based medical device development company focused on creating fluid-based intraocular lens implants. The acquisition furthers Alcon’s commitment to bring this innovative, accommodating lens to cataract patients ALCON - FINANCIALS - ANNUAL REPORTS Alcon is incorporated outside the U.S. and qualifies as a foreign private issuer, or FPI. As long as we qualify as an FPI, we will be exempt from certain provisions of the Securities Exchange Act of 1934 that are applicable to U.S. domestic public companies, including: regulations governing the solicitation of proxies; consents or authorizations in respect of registered securities ALCON INTRODUCES NEWLY OPTIMIZED ULTRASERT® PRE-LOADED NEW ORLEANS, November 9, 2017 – Alcon, the global leader in eye care and a division of Novartis, will introduce the newly optimized UltraSert® delivery system pre-loaded with the AcrySof® IQ aspheric monofocal intraocular lens (IOL) for people undergoing cataract surgery at the 2017 American Academy of Ophthalmology (AAO) annual meeting, taking place November 11 – 14 in New Orleans. ALCON - ALCON FILES FINAL 20F To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address.HOME | AU.ALCON.COM
See Brilliantly. We aspire to lead the world in innovating life-changing vision and eye care products because when people see brilliantly, they live brilliantly. lightshow. About Alcon. Careers. Corporate Responsibility. Please wait for your event to start. The event has now ended. 0:00 | 1:27 LIVE. ALCON OFFICIAL SITE: DEVELOPING INNOVATIVE EYE CAREINNOVATIONCONTACT USCAREER SEARCHABOUT USINVESTOR RELATIONSMEDIA RELEASES At Alcon, we are proudly committed to creating a work culture that welcomes and celebrates diversity and inclusion. That’s why we are thrilled Alcon has earned a 95 percent rating on the Human Rights Campaign’s 2021 Corporate Equality Index.. Now in its 19th year, the Human Rights Campaign’s annual survey examines corporate policies and practices related to workplace equality for lesbian NEW ALCON DATA ON CONTACT LENS, DRY EYE AND OCULAR HEALTH Alcon, the global leader in eye care, will present new data on several of its latest contact lens, dry eye and ocular health innovations during the Association for Research in Vision and Ophthalmology (ARVO) 2021 virtual meeting taking place May 1-7. Alcon boasts a robust scientific showing at the meeting with nine accepted abstracts on vision care innovations including theALCON: CAREERS
Alcon is an Equal Opportunity Employer and participates in E-Verify. Alcon takes pride in maintaining a diverse environment and our policies are not to discriminate in recruitment, hiring, training, promotion or other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, gender identity, marital or veteran status, disability, or any other ALCON - NEWS AND EVENTS - EVENTS & PRESENTATIONS Alcon’s Fourth Quarter and Full Year 2020 Earnings Conference Call. Webcast (opens in new window) Earnings Release (opens in new window) Form 20-F (opens in new window) Regulatory Filing (opens in new window) Presentation (opens in new window) 01/12/2021 02:00 PM ET. 39th Annual JP Morgan Healthcare Conference. Webcast (opens in newwindow)
ALCON
Convert K-readings to initial recommendation for our soft lensproducts. Content:
ALCON ANNOUNCES ACQUISITION OF POWERVISION, INC. Fort Worth, Texas, March 18, 2019 – Alcon, the global leader in eye care and a division of Novartis, announced today that it has acquired PowerVision, Inc., a privately-held, US-based medical device development company focused on creating fluid-based intraocular lens implants. The acquisition furthers Alcon’s commitment to bring this innovative, accommodating lens to cataract patients ALCON - FINANCIALS - ANNUAL REPORTS Alcon is incorporated outside the U.S. and qualifies as a foreign private issuer, or FPI. As long as we qualify as an FPI, we will be exempt from certain provisions of the Securities Exchange Act of 1934 that are applicable to U.S. domestic public companies, including: regulations governing the solicitation of proxies; consents or authorizations in respect of registered securities ALCON INTRODUCES NEWLY OPTIMIZED ULTRASERT® PRE-LOADED NEW ORLEANS, November 9, 2017 – Alcon, the global leader in eye care and a division of Novartis, will introduce the newly optimized UltraSert® delivery system pre-loaded with the AcrySof® IQ aspheric monofocal intraocular lens (IOL) for people undergoing cataract surgery at the 2017 American Academy of Ophthalmology (AAO) annual meeting, taking place November 11 – 14 in New Orleans. ALCON - ALCON FILES FINAL 20F To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address.HOME | AU.ALCON.COM
See Brilliantly. We aspire to lead the world in innovating life-changing vision and eye care products because when people see brilliantly, they live brilliantly. lightshow. About Alcon. Careers. Corporate Responsibility. Please wait for your event to start. The event has now ended. 0:00 | 1:27 LIVE. NEW ALCON DATA ON CONTACT LENS, DRY EYE AND OCULAR HEALTH Alcon, the global leader in eye care, will present new data on several of its latest contact lens, dry eye and ocular health innovations during the Association for Research in Vision and Ophthalmology (ARVO) 2021 virtual meeting taking place May 1-7. Alcon boasts a robust scientific showing at the meeting with nine accepted abstracts on vision care innovations including the ALCON TO SHOWCASE VISION CARE INNOVATION, INCLUDING .q4default .bwlistdecimal { list-style-type: decimal }.q4default .bwlistdisc { list-style-type: disc }.q4default .bwuline { text-decoration: underline } 18 abstracts accepted, underscoring Alcon’s commitment to vision, comfort and ocular surface health TOTAL30 designed with water gradient technology that has biomimetic properties that mimic the corneal surface and demonstratesALCON PATENT LIST
The following products are protected by U.S. patents as indicated below. This website is provided to satisfy the virtual patent marking provisions of the America Invents Act under 35 U.S.C. § 287(a). The following list of products may not be all inclusive, and other products not listed here may be protected by one or more patents. ALCON INTRODUCES SYSTANE® HYDRATION PRESERVATIVE-FREE March 5, 2020 Alcon, the global leader in eye care and Official Sponsor of 20/20™, today introduced SYSTANE® HYDRATION Preservative-Free (PF), the latest addition to the #1 doctor recommended SYSTANE Family of Products, at the SECO International 2020 meeting (#SECO2020). SYSTANE HYDRATION PF Lubricant Eye Drops is a new preservative-free option for dry eye sufferers CORPORATE SOCIAL RESPONSIBILITY Corporate Responsibility Report. Alcon has been actively engaged in environmental, social and governance (ESG) initiatives during our 70+ years in ophthalmology and optometry. In publishing our first Corporate Responsibility Report as an independent, standalone company, we are sharing our perspective on corporate citizenship anddemonstrating
ALCON - NEWS AND EVENTS - EVENTS & PRESENTATIONS Alcon’s Fourth Quarter and Full Year 2020 Earnings Conference Call. Webcast (opens in new window) Earnings Release (opens in new window) Form 20-F (opens in new window) Regulatory Filing (opens in new window) Presentation (opens in new window) 01/12/2021 02:00 PM ET. 39th Annual JP Morgan Healthcare Conference. Webcast (opens in newwindow)
ALCON ANNOUNCES LAUNCH OF ACRYSOF IQ VIVITY, THE FIRST AND Vivity is a first-of-its-kind, non-diffractive extended depth of focus IOL with Alcon’s proprietary non-diffractive X-WAVE™ technology, which stretches and shifts light without splitting it. 1 Vivity delivers monofocal-quality distance (far) with excellent intermediate (at arm’s length) and functional near vision (up close). *2 The lens expands Alcon’s growing portfolio of presbyopia ALCON FEATURES NEW TECHNOLOGY UPGRADES FOR THE ORA SYSTEM San Diego, California, April 14, 2015 – Alcon, the global leader in eye care, will introduce enhancements to both the ORA System ® and the VERION™ Image Guided System, providing improved capabilities and efficiency during both preoperative planning and intraoperative guidance during the cataract surgery procedure. The new VerifEye+™ Technology and VERION 2.6 software update will be ALCON INTRODUCES NEWLY OPTIMIZED ULTRASERT® PRE-LOADED NEW ORLEANS, November 9, 2017 – Alcon, the global leader in eye care and a division of Novartis, will introduce the newly optimized UltraSert® delivery system pre-loaded with the AcrySof® IQ aspheric monofocal intraocular lens (IOL) for people undergoing cataract surgery at the 2017 American Academy of Ophthalmology (AAO) annual meeting, taking place November 11 – 14 in New Orleans. HOME | ALCON.COMTRANSLATE THIS PAGE Wie optimaal ziet, leeft optimaal. Daarom streeft Alcon er elke dag naar om wereldleider te zijn in het bieden van optimale ooggezondheid en innoverende oogzorgproducten. lightshow. Over Alcon. Carrière bijAlcon.
ALCON OFFICIAL SITE: DEVELOPING INNOVATIVE EYE CAREINNOVATIONCONTACT USCAREER SEARCHABOUT USINVESTOR RELATIONSMEDIA RELEASES At Alcon, we are proudly committed to creating a work culture that welcomes and celebrates diversity and inclusion. That’s why we are thrilled Alcon has earned a 95 percent rating on the Human Rights Campaign’s 2021 Corporate Equality Index.. Now in its 19th year, the Human Rights Campaign’s annual survey examines corporate policies and practices related to workplace equality for lesbian NEW ALCON DATA ON CONTACT LENS, DRY EYE AND OCULAR HEALTH Alcon, the global leader in eye care, will present new data on several of its latest contact lens, dry eye and ocular health innovations during the Association for Research in Vision and Ophthalmology (ARVO) 2021 virtual meeting taking place May 1-7. Alcon boasts a robust scientific showing at the meeting with nine accepted abstracts on vision care innovations including theALCON: CAREERS
Alcon is an Equal Opportunity Employer and participates in E-Verify. Alcon takes pride in maintaining a diverse environment and our policies are not to discriminate in recruitment, hiring, training, promotion or other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, gender identity, marital or veteran status, disability, or any other ALCON - NEWS AND EVENTS - EVENTS & PRESENTATIONS Alcon’s Fourth Quarter and Full Year 2020 Earnings Conference Call. Webcast (opens in new window) Earnings Release (opens in new window) Form 20-F (opens in new window) Regulatory Filing (opens in new window) Presentation (opens in new window) 01/12/2021 02:00 PM ET. 39th Annual JP Morgan Healthcare Conference. Webcast (opens in newwindow)
ALCON
Convert K-readings to initial recommendation for our soft lensproducts. Content:
ALCON ANNOUNCES ACQUISITION OF POWERVISION, INC. Fort Worth, Texas, March 18, 2019 – Alcon, the global leader in eye care and a division of Novartis, announced today that it has acquired PowerVision, Inc., a privately-held, US-based medical device development company focused on creating fluid-based intraocular lens implants. The acquisition furthers Alcon’s commitment to bring this innovative, accommodating lens to cataract patients ALCON - FINANCIALS - ANNUAL REPORTS Alcon is incorporated outside the U.S. and qualifies as a foreign private issuer, or FPI. As long as we qualify as an FPI, we will be exempt from certain provisions of the Securities Exchange Act of 1934 that are applicable to U.S. domestic public companies, including: regulations governing the solicitation of proxies; consents or authorizations in respect of registered securities ALCON INTRODUCES NEWLY OPTIMIZED ULTRASERT® PRE-LOADED NEW ORLEANS, November 9, 2017 – Alcon, the global leader in eye care and a division of Novartis, will introduce the newly optimized UltraSert® delivery system pre-loaded with the AcrySof® IQ aspheric monofocal intraocular lens (IOL) for people undergoing cataract surgery at the 2017 American Academy of Ophthalmology (AAO) annual meeting, taking place November 11 – 14 in New Orleans. ALCON - ALCON FILES FINAL 20F To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address.HOME | AU.ALCON.COM
See Brilliantly. We aspire to lead the world in innovating life-changing vision and eye care products because when people see brilliantly, they live brilliantly. lightshow. About Alcon. Careers. Corporate Responsibility. Please wait for your event to start. The event has now ended. 0:00 | 1:27 LIVE. ALCON OFFICIAL SITE: DEVELOPING INNOVATIVE EYE CAREINNOVATIONCONTACT USCAREER SEARCHABOUT USINVESTOR RELATIONSMEDIA RELEASES At Alcon, we are proudly committed to creating a work culture that welcomes and celebrates diversity and inclusion. That’s why we are thrilled Alcon has earned a 95 percent rating on the Human Rights Campaign’s 2021 Corporate Equality Index.. Now in its 19th year, the Human Rights Campaign’s annual survey examines corporate policies and practices related to workplace equality for lesbian NEW ALCON DATA ON CONTACT LENS, DRY EYE AND OCULAR HEALTH Alcon, the global leader in eye care, will present new data on several of its latest contact lens, dry eye and ocular health innovations during the Association for Research in Vision and Ophthalmology (ARVO) 2021 virtual meeting taking place May 1-7. Alcon boasts a robust scientific showing at the meeting with nine accepted abstracts on vision care innovations including theALCON: CAREERS
Alcon is an Equal Opportunity Employer and participates in E-Verify. Alcon takes pride in maintaining a diverse environment and our policies are not to discriminate in recruitment, hiring, training, promotion or other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, gender identity, marital or veteran status, disability, or any other ALCON - NEWS AND EVENTS - EVENTS & PRESENTATIONS Alcon’s Fourth Quarter and Full Year 2020 Earnings Conference Call. Webcast (opens in new window) Earnings Release (opens in new window) Form 20-F (opens in new window) Regulatory Filing (opens in new window) Presentation (opens in new window) 01/12/2021 02:00 PM ET. 39th Annual JP Morgan Healthcare Conference. Webcast (opens in newwindow)
ALCON
Convert K-readings to initial recommendation for our soft lensproducts. Content:
ALCON ANNOUNCES ACQUISITION OF POWERVISION, INC. Fort Worth, Texas, March 18, 2019 – Alcon, the global leader in eye care and a division of Novartis, announced today that it has acquired PowerVision, Inc., a privately-held, US-based medical device development company focused on creating fluid-based intraocular lens implants. The acquisition furthers Alcon’s commitment to bring this innovative, accommodating lens to cataract patients ALCON - FINANCIALS - ANNUAL REPORTS Alcon is incorporated outside the U.S. and qualifies as a foreign private issuer, or FPI. As long as we qualify as an FPI, we will be exempt from certain provisions of the Securities Exchange Act of 1934 that are applicable to U.S. domestic public companies, including: regulations governing the solicitation of proxies; consents or authorizations in respect of registered securities ALCON INTRODUCES NEWLY OPTIMIZED ULTRASERT® PRE-LOADED NEW ORLEANS, November 9, 2017 – Alcon, the global leader in eye care and a division of Novartis, will introduce the newly optimized UltraSert® delivery system pre-loaded with the AcrySof® IQ aspheric monofocal intraocular lens (IOL) for people undergoing cataract surgery at the 2017 American Academy of Ophthalmology (AAO) annual meeting, taking place November 11 – 14 in New Orleans. ALCON - ALCON FILES FINAL 20F To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address.HOME | AU.ALCON.COM
See Brilliantly. We aspire to lead the world in innovating life-changing vision and eye care products because when people see brilliantly, they live brilliantly. lightshow. About Alcon. Careers. Corporate Responsibility. Please wait for your event to start. The event has now ended. 0:00 | 1:27 LIVE. NEW ALCON DATA ON CONTACT LENS, DRY EYE AND OCULAR HEALTH Alcon, the global leader in eye care, will present new data on several of its latest contact lens, dry eye and ocular health innovations during the Association for Research in Vision and Ophthalmology (ARVO) 2021 virtual meeting taking place May 1-7. Alcon boasts a robust scientific showing at the meeting with nine accepted abstracts on vision care innovations including the ALCON TO SHOWCASE VISION CARE INNOVATION, INCLUDING .q4default .bwlistdecimal { list-style-type: decimal }.q4default .bwlistdisc { list-style-type: disc }.q4default .bwuline { text-decoration: underline } 18 abstracts accepted, underscoring Alcon’s commitment to vision, comfort and ocular surface health TOTAL30 designed with water gradient technology that has biomimetic properties that mimic the corneal surface and demonstratesALCON PATENT LIST
The following products are protected by U.S. patents as indicated below. This website is provided to satisfy the virtual patent marking provisions of the America Invents Act under 35 U.S.C. § 287(a). The following list of products may not be all inclusive, and other products not listed here may be protected by one or more patents. ALCON INTRODUCES SYSTANE® HYDRATION PRESERVATIVE-FREE March 5, 2020 Alcon, the global leader in eye care and Official Sponsor of 20/20™, today introduced SYSTANE® HYDRATION Preservative-Free (PF), the latest addition to the #1 doctor recommended SYSTANE Family of Products, at the SECO International 2020 meeting (#SECO2020). SYSTANE HYDRATION PF Lubricant Eye Drops is a new preservative-free option for dry eye sufferers CORPORATE SOCIAL RESPONSIBILITY Corporate Responsibility Report. Alcon has been actively engaged in environmental, social and governance (ESG) initiatives during our 70+ years in ophthalmology and optometry. In publishing our first Corporate Responsibility Report as an independent, standalone company, we are sharing our perspective on corporate citizenship anddemonstrating
ALCON - NEWS AND EVENTS - EVENTS & PRESENTATIONS Alcon’s Fourth Quarter and Full Year 2020 Earnings Conference Call. Webcast (opens in new window) Earnings Release (opens in new window) Form 20-F (opens in new window) Regulatory Filing (opens in new window) Presentation (opens in new window) 01/12/2021 02:00 PM ET. 39th Annual JP Morgan Healthcare Conference. Webcast (opens in newwindow)
ALCON ANNOUNCES LAUNCH OF ACRYSOF IQ VIVITY, THE FIRST AND Vivity is a first-of-its-kind, non-diffractive extended depth of focus IOL with Alcon’s proprietary non-diffractive X-WAVE™ technology, which stretches and shifts light without splitting it. 1 Vivity delivers monofocal-quality distance (far) with excellent intermediate (at arm’s length) and functional near vision (up close). *2 The lens expands Alcon’s growing portfolio of presbyopia ALCON FEATURES NEW TECHNOLOGY UPGRADES FOR THE ORA SYSTEM San Diego, California, April 14, 2015 – Alcon, the global leader in eye care, will introduce enhancements to both the ORA System ® and the VERION™ Image Guided System, providing improved capabilities and efficiency during both preoperative planning and intraoperative guidance during the cataract surgery procedure. The new VerifEye+™ Technology and VERION 2.6 software update will be ALCON INTRODUCES NEWLY OPTIMIZED ULTRASERT® PRE-LOADED NEW ORLEANS, November 9, 2017 – Alcon, the global leader in eye care and a division of Novartis, will introduce the newly optimized UltraSert® delivery system pre-loaded with the AcrySof® IQ aspheric monofocal intraocular lens (IOL) for people undergoing cataract surgery at the 2017 American Academy of Ophthalmology (AAO) annual meeting, taking place November 11 – 14 in New Orleans. HOME | ALCON.COMTRANSLATE THIS PAGE Wie optimaal ziet, leeft optimaal. Daarom streeft Alcon er elke dag naar om wereldleider te zijn in het bieden van optimale ooggezondheid en innoverende oogzorgproducten. lightshow. Over Alcon. Carrière bijAlcon.
ALCON OFFICIAL SITE: DEVELOPING INNOVATIVE EYE CAREINNOVATIONCONTACT USCAREER SEARCHABOUT USINVESTOR RELATIONSMEDIA RELEASES At Alcon, we are proudly committed to creating a work culture that welcomes and celebrates diversity and inclusion. That’s why we are thrilled Alcon has earned a 95 percent rating on the Human Rights Campaign’s 2021 Corporate Equality Index.. Now in its 19th year, the Human Rights Campaign’s annual survey examines corporate policies and practices related to workplace equality for lesbianALCON: CAREERS
Alcon is an Equal Opportunity Employer and participates in E-Verify. Alcon takes pride in maintaining a diverse environment and our policies are not to discriminate in recruitment, hiring, training, promotion or other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, gender identity, marital or veteran status, disability, or any other CORPORATE SOCIAL RESPONSIBILITY Corporate Responsibility Report. Alcon has been actively engaged in environmental, social and governance (ESG) initiatives during our 70+ years in ophthalmology and optometry. In publishing our first Corporate Responsibility Report as an independent, standalone company, we are sharing our perspective on corporate citizenship anddemonstrating
RESPONSIBLE BUSINESS PRACTICE The Alcon Ethics Helpline is an independently managed, confidential online and telephone service available 24 hours a day, 7 days a week, in multiple languages. Concerns may be reported anonymously through the Helpline, where allowed under local law. For details about how to report, visit Alcon.Ethicspoint.com.ALCON
Convert K-readings to initial recommendation for our soft lensproducts. Content:
ALCON - NEWS AND EVENTS - EVENTS & PRESENTATIONS Alcon’s Fourth Quarter and Full Year 2020 Earnings Conference Call. Webcast (opens in new window) Earnings Release (opens in new window) Form 20-F (opens in new window) Regulatory Filing (opens in new window) Presentation (opens in new window) 01/12/2021 02:00 PM ET. 39th Annual JP Morgan Healthcare Conference. Webcast (opens in newwindow)
ALCON - INVESTOR RELATIONS Alcon is the world leader in eye care, dedicated to helping people see brilliantly. With our 70-plus-year heritage, we are the largest eye care device company in the world – with complementary businesses in Surgical and Vision Care. ALCON ANNOUNCES LAUNCH OF ACRYSOF IQ VIVITY, THE FIRST AND Vivity is a first-of-its-kind, non-diffractive extended depth of focus IOL with Alcon’s proprietary non-diffractive X-WAVE™ technology, which stretches and shifts light without splitting it. 1 Vivity delivers monofocal-quality distance (far) with excellent intermediate (at arm’s length) and functional near vision (up close). *2 The lens expands Alcon’s growing portfolio of presbyopia ALCON - FINANCIALS - ANNUAL REPORTS Alcon is incorporated outside the U.S. and qualifies as a foreign private issuer, or FPI. As long as we qualify as an FPI, we will be exempt from certain provisions of the Securities Exchange Act of 1934 that are applicable to U.S. domestic public companies, including: regulations governing the solicitation of proxies; consents or authorizations in respect of registered securities ALCON - ALCON FILES FINAL 20F To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. ALCON OFFICIAL SITE: DEVELOPING INNOVATIVE EYE CAREINNOVATIONCONTACT USCAREER SEARCHABOUT USINVESTOR RELATIONSMEDIA RELEASES At Alcon, we are proudly committed to creating a work culture that welcomes and celebrates diversity and inclusion. That’s why we are thrilled Alcon has earned a 95 percent rating on the Human Rights Campaign’s 2021 Corporate Equality Index.. Now in its 19th year, the Human Rights Campaign’s annual survey examines corporate policies and practices related to workplace equality for lesbianALCON: CAREERS
Alcon is an Equal Opportunity Employer and participates in E-Verify. Alcon takes pride in maintaining a diverse environment and our policies are not to discriminate in recruitment, hiring, training, promotion or other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, gender identity, marital or veteran status, disability, or any other CORPORATE SOCIAL RESPONSIBILITY Corporate Responsibility Report. Alcon has been actively engaged in environmental, social and governance (ESG) initiatives during our 70+ years in ophthalmology and optometry. In publishing our first Corporate Responsibility Report as an independent, standalone company, we are sharing our perspective on corporate citizenship anddemonstrating
RESPONSIBLE BUSINESS PRACTICE The Alcon Ethics Helpline is an independently managed, confidential online and telephone service available 24 hours a day, 7 days a week, in multiple languages. Concerns may be reported anonymously through the Helpline, where allowed under local law. For details about how to report, visit Alcon.Ethicspoint.com.ALCON
Convert K-readings to initial recommendation for our soft lensproducts. Content:
ALCON - NEWS AND EVENTS - EVENTS & PRESENTATIONS Alcon’s Fourth Quarter and Full Year 2020 Earnings Conference Call. Webcast (opens in new window) Earnings Release (opens in new window) Form 20-F (opens in new window) Regulatory Filing (opens in new window) Presentation (opens in new window) 01/12/2021 02:00 PM ET. 39th Annual JP Morgan Healthcare Conference. Webcast (opens in newwindow)
ALCON - INVESTOR RELATIONS Alcon is the world leader in eye care, dedicated to helping people see brilliantly. With our 70-plus-year heritage, we are the largest eye care device company in the world – with complementary businesses in Surgical and Vision Care. ALCON ANNOUNCES LAUNCH OF ACRYSOF IQ VIVITY, THE FIRST AND Vivity is a first-of-its-kind, non-diffractive extended depth of focus IOL with Alcon’s proprietary non-diffractive X-WAVE™ technology, which stretches and shifts light without splitting it. 1 Vivity delivers monofocal-quality distance (far) with excellent intermediate (at arm’s length) and functional near vision (up close). *2 The lens expands Alcon’s growing portfolio of presbyopia ALCON - FINANCIALS - ANNUAL REPORTS Alcon is incorporated outside the U.S. and qualifies as a foreign private issuer, or FPI. As long as we qualify as an FPI, we will be exempt from certain provisions of the Securities Exchange Act of 1934 that are applicable to U.S. domestic public companies, including: regulations governing the solicitation of proxies; consents or authorizations in respect of registered securities ALCON - ALCON FILES FINAL 20F To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. ALCON TO SHOWCASE VISION CARE INNOVATION, INCLUDING .q4default .bwlistdecimal { list-style-type: decimal }.q4default .bwlistdisc { list-style-type: disc }.q4default .bwuline { text-decoration: underline } 18 abstracts accepted, underscoring Alcon’s commitment to vision, comfort and ocular surface health TOTAL30 designed with water gradient technology that has biomimetic properties that mimic the corneal surface and demonstrates TECHNICAL PRODUCT INFORMATION ACRYSERT® Delivery System MODEL SN6CWS Product Information ACRYSOF® Aspheric UV Absorbing ReSTOR +2.5 D Toric IOL ALCON RESEARCH INSTITUTE Alcon Research Institute. In 1981, Alcon set out to help support research in eye health and to expand the frontiers of vision sciences globally – from this concept Alcon Research Institute (ARI) was born. Since then, the ARI has had a significant impact on the study of ocular diseases and has become a bridge to building partnerships with ALCON ANNOUNCES LAUNCH OF ACRYSOF IQ VIVITY, THE FIRST AND Vivity is a first-of-its-kind, non-diffractive extended depth of focus IOL with Alcon’s proprietary non-diffractive X-WAVE™ technology, which stretches and shifts light without splitting it. 1 Vivity delivers monofocal-quality distance (far) with excellent intermediate (at arm’s length) and functional near vision (up close). *2 The lens expands Alcon’s growing portfolio of presbyopia ALCON - NEWS AND EVENTS - EVENTS & PRESENTATIONS Alcon’s Fourth Quarter and Full Year 2020 Earnings Conference Call. Webcast (opens in new window) Earnings Release (opens in new window) Form 20-F (opens in new window) Regulatory Filing (opens in new window) Presentation (opens in new window) 01/12/2021 02:00 PM ET. 39th Annual JP Morgan Healthcare Conference. Webcast (opens in newwindow)
ALCON - INVESTOR RELATIONS Alcon is the world leader in eye care, dedicated to helping people see brilliantly. With our 70-plus-year heritage, we are the largest eye care device company in the world – with complementary businesses in Surgical and Vision Care. JOB SEARCH | ALCON.COM Privacy Policy; Cookie Notice; Terms of Use; Investors; Site Map; California Resident? Do Not Sell My Personal Information ALCON FEATURES NEW TECHNOLOGY UPGRADES FOR THE ORA SYSTEM San Diego, California, April 14, 2015 – Alcon, the global leader in eye care, will introduce enhancements to both the ORA System ® and the VERION™ Image Guided System, providing improved capabilities and efficiency during both preoperative planning and intraoperative guidance during the cataract surgery procedure. The new VerifEye+™ Technology and VERION 2.6 software update will be ALCON - FINANCIALS - QUARTERLY RESULTS Alcon is incorporated outside the U.S. and qualifies as a foreign private issuer, or FPI. As long as we qualify as an FPI, we will be exempt from certain provisions of the Securities Exchange Act of 1934 that are applicable to U.S. domestic public companies, including: regulations governing the solicitation of proxies; consents or authorizations in respect of registered securitiesHOME | AU.ALCON.COM
See Brilliantly. We aspire to lead the world in innovating life-changing vision and eye care products because when people see brilliantly, they live brilliantly. lightshow. About Alcon. Careers. Corporate Responsibility. Please wait for your event to start. The event has now ended. 0:00 | 1:27 LIVE. ALCON OFFICIAL SITE: DEVELOPING INNOVATIVE EYE CAREINNOVATIONCONTACT USCAREER SEARCHABOUT USINVESTOR RELATIONSMEDIA RELEASES At Alcon, we are proudly committed to creating a work culture that welcomes and celebrates diversity and inclusion. That’s why we are thrilled Alcon has earned a 95 percent rating on the Human Rights Campaign’s 2021 Corporate Equality Index.. Now in its 19th year, the Human Rights Campaign’s annual survey examines corporate policies and practices related to workplace equality for lesbianALCON: CAREERS
Alcon is an Equal Opportunity Employer and participates in E-Verify. Alcon takes pride in maintaining a diverse environment and our policies are not to discriminate in recruitment, hiring, training, promotion or other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, gender identity, marital or veteran status, disability, or any other CORPORATE SOCIAL RESPONSIBILITY Corporate Responsibility Report. Alcon has been actively engaged in environmental, social and governance (ESG) initiatives during our 70+ years in ophthalmology and optometry. In publishing our first Corporate Responsibility Report as an independent, standalone company, we are sharing our perspective on corporate citizenship anddemonstrating
RESPONSIBLE BUSINESS PRACTICE The Alcon Ethics Helpline is an independently managed, confidential online and telephone service available 24 hours a day, 7 days a week, in multiple languages. Concerns may be reported anonymously through the Helpline, where allowed under local law. For details about how to report, visit Alcon.Ethicspoint.com.ALCON
Convert K-readings to initial recommendation for our soft lensproducts. Content:
ALCON - NEWS AND EVENTS - EVENTS & PRESENTATIONS Alcon’s Fourth Quarter and Full Year 2020 Earnings Conference Call. Webcast (opens in new window) Earnings Release (opens in new window) Form 20-F (opens in new window) Regulatory Filing (opens in new window) Presentation (opens in new window) 01/12/2021 02:00 PM ET. 39th Annual JP Morgan Healthcare Conference. Webcast (opens in newwindow)
ALCON - INVESTOR RELATIONS Alcon is the world leader in eye care, dedicated to helping people see brilliantly. With our 70-plus-year heritage, we are the largest eye care device company in the world – with complementary businesses in Surgical and Vision Care. ALCON ANNOUNCES LAUNCH OF ACRYSOF IQ VIVITY, THE FIRST AND Vivity is a first-of-its-kind, non-diffractive extended depth of focus IOL with Alcon’s proprietary non-diffractive X-WAVE™ technology, which stretches and shifts light without splitting it. 1 Vivity delivers monofocal-quality distance (far) with excellent intermediate (at arm’s length) and functional near vision (up close). *2 The lens expands Alcon’s growing portfolio of presbyopia ALCON - FINANCIALS - ANNUAL REPORTS Alcon is incorporated outside the U.S. and qualifies as a foreign private issuer, or FPI. As long as we qualify as an FPI, we will be exempt from certain provisions of the Securities Exchange Act of 1934 that are applicable to U.S. domestic public companies, including: regulations governing the solicitation of proxies; consents or authorizations in respect of registered securities ALCON - ALCON FILES FINAL 20F To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. ALCON OFFICIAL SITE: DEVELOPING INNOVATIVE EYE CAREINNOVATIONCONTACT USCAREER SEARCHABOUT USINVESTOR RELATIONSMEDIA RELEASES At Alcon, we are proudly committed to creating a work culture that welcomes and celebrates diversity and inclusion. That’s why we are thrilled Alcon has earned a 95 percent rating on the Human Rights Campaign’s 2021 Corporate Equality Index.. Now in its 19th year, the Human Rights Campaign’s annual survey examines corporate policies and practices related to workplace equality for lesbianALCON: CAREERS
Alcon is an Equal Opportunity Employer and participates in E-Verify. Alcon takes pride in maintaining a diverse environment and our policies are not to discriminate in recruitment, hiring, training, promotion or other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, gender identity, marital or veteran status, disability, or any other CORPORATE SOCIAL RESPONSIBILITY Corporate Responsibility Report. Alcon has been actively engaged in environmental, social and governance (ESG) initiatives during our 70+ years in ophthalmology and optometry. In publishing our first Corporate Responsibility Report as an independent, standalone company, we are sharing our perspective on corporate citizenship anddemonstrating
RESPONSIBLE BUSINESS PRACTICE The Alcon Ethics Helpline is an independently managed, confidential online and telephone service available 24 hours a day, 7 days a week, in multiple languages. Concerns may be reported anonymously through the Helpline, where allowed under local law. For details about how to report, visit Alcon.Ethicspoint.com.ALCON
Convert K-readings to initial recommendation for our soft lensproducts. Content:
ALCON - NEWS AND EVENTS - EVENTS & PRESENTATIONS Alcon’s Fourth Quarter and Full Year 2020 Earnings Conference Call. Webcast (opens in new window) Earnings Release (opens in new window) Form 20-F (opens in new window) Regulatory Filing (opens in new window) Presentation (opens in new window) 01/12/2021 02:00 PM ET. 39th Annual JP Morgan Healthcare Conference. Webcast (opens in newwindow)
ALCON - INVESTOR RELATIONS Alcon is the world leader in eye care, dedicated to helping people see brilliantly. With our 70-plus-year heritage, we are the largest eye care device company in the world – with complementary businesses in Surgical and Vision Care. ALCON ANNOUNCES LAUNCH OF ACRYSOF IQ VIVITY, THE FIRST AND Vivity is a first-of-its-kind, non-diffractive extended depth of focus IOL with Alcon’s proprietary non-diffractive X-WAVE™ technology, which stretches and shifts light without splitting it. 1 Vivity delivers monofocal-quality distance (far) with excellent intermediate (at arm’s length) and functional near vision (up close). *2 The lens expands Alcon’s growing portfolio of presbyopia ALCON - FINANCIALS - ANNUAL REPORTS Alcon is incorporated outside the U.S. and qualifies as a foreign private issuer, or FPI. As long as we qualify as an FPI, we will be exempt from certain provisions of the Securities Exchange Act of 1934 that are applicable to U.S. domestic public companies, including: regulations governing the solicitation of proxies; consents or authorizations in respect of registered securities ALCON - ALCON FILES FINAL 20F To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. ALCON TO SHOWCASE VISION CARE INNOVATION, INCLUDING .q4default .bwlistdecimal { list-style-type: decimal }.q4default .bwlistdisc { list-style-type: disc }.q4default .bwuline { text-decoration: underline } 18 abstracts accepted, underscoring Alcon’s commitment to vision, comfort and ocular surface health TOTAL30 designed with water gradient technology that has biomimetic properties that mimic the corneal surface and demonstrates TECHNICAL PRODUCT INFORMATION ACRYSERT® Delivery System MODEL SN6CWS Product Information ACRYSOF® Aspheric UV Absorbing ReSTOR +2.5 D Toric IOL ALCON RESEARCH INSTITUTE Alcon Research Institute. In 1981, Alcon set out to help support research in eye health and to expand the frontiers of vision sciences globally – from this concept Alcon Research Institute (ARI) was born. Since then, the ARI has had a significant impact on the study of ocular diseases and has become a bridge to building partnerships with ALCON ANNOUNCES LAUNCH OF ACRYSOF IQ VIVITY, THE FIRST AND Vivity is a first-of-its-kind, non-diffractive extended depth of focus IOL with Alcon’s proprietary non-diffractive X-WAVE™ technology, which stretches and shifts light without splitting it. 1 Vivity delivers monofocal-quality distance (far) with excellent intermediate (at arm’s length) and functional near vision (up close). *2 The lens expands Alcon’s growing portfolio of presbyopia ALCON - NEWS AND EVENTS - EVENTS & PRESENTATIONS Alcon’s Fourth Quarter and Full Year 2020 Earnings Conference Call. Webcast (opens in new window) Earnings Release (opens in new window) Form 20-F (opens in new window) Regulatory Filing (opens in new window) Presentation (opens in new window) 01/12/2021 02:00 PM ET. 39th Annual JP Morgan Healthcare Conference. Webcast (opens in newwindow)
ALCON - INVESTOR RELATIONS Alcon is the world leader in eye care, dedicated to helping people see brilliantly. With our 70-plus-year heritage, we are the largest eye care device company in the world – with complementary businesses in Surgical and Vision Care. JOB SEARCH | ALCON.COM Privacy Policy; Cookie Notice; Terms of Use; Investors; Site Map; California Resident? Do Not Sell My Personal Information ALCON FEATURES NEW TECHNOLOGY UPGRADES FOR THE ORA SYSTEM San Diego, California, April 14, 2015 – Alcon, the global leader in eye care, will introduce enhancements to both the ORA System ® and the VERION™ Image Guided System, providing improved capabilities and efficiency during both preoperative planning and intraoperative guidance during the cataract surgery procedure. The new VerifEye+™ Technology and VERION 2.6 software update will be ALCON - FINANCIALS - QUARTERLY RESULTS Alcon is incorporated outside the U.S. and qualifies as a foreign private issuer, or FPI. As long as we qualify as an FPI, we will be exempt from certain provisions of the Securities Exchange Act of 1934 that are applicable to U.S. domestic public companies, including: regulations governing the solicitation of proxies; consents or authorizations in respect of registered securitiesHOME | AU.ALCON.COM
See Brilliantly. We aspire to lead the world in innovating life-changing vision and eye care products because when people see brilliantly, they live brilliantly. lightshow. About Alcon. Careers. Corporate Responsibility. Please wait for your event to start. The event has now ended. 0:00 | 1:27 LIVE. ALCON OFFICIAL SITE: DEVELOPING INNOVATIVE EYE CAREINNOVATIONCONTACT USCAREER SEARCHABOUT USINVESTOR RELATIONSMEDIA RELEASES At Alcon, we are proudly committed to creating a work culture that welcomes and celebrates diversity and inclusion. That’s why we are thrilled Alcon has earned a 95 percent rating on the Human Rights Campaign’s 2021 Corporate Equality Index.. Now in its 19th year, the Human Rights Campaign’s annual survey examines corporate policies and practices related to workplace equality for lesbianALCON: CAREERS
Alcon is an Equal Opportunity Employer and participates in E-Verify. Alcon takes pride in maintaining a diverse environment and our policies are not to discriminate in recruitment, hiring, training, promotion or other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, gender identity, marital or veteran status, disability, or any other CORPORATE SOCIAL RESPONSIBILITY Corporate Responsibility Report. Alcon has been actively engaged in environmental, social and governance (ESG) initiatives during our 70+ years in ophthalmology and optometry. In publishing our first Corporate Responsibility Report as an independent, standalone company, we are sharing our perspective on corporate citizenship anddemonstrating
RESPONSIBLE BUSINESS PRACTICE The Alcon Ethics Helpline is an independently managed, confidential online and telephone service available 24 hours a day, 7 days a week, in multiple languages. Concerns may be reported anonymously through the Helpline, where allowed under local law. For details about how to report, visit Alcon.Ethicspoint.com.ALCON
Convert K-readings to initial recommendation for our soft lensproducts. Content:
ALCON - NEWS AND EVENTS - EVENTS & PRESENTATIONS Alcon’s Fourth Quarter and Full Year 2020 Earnings Conference Call. Webcast (opens in new window) Earnings Release (opens in new window) Form 20-F (opens in new window) Regulatory Filing (opens in new window) Presentation (opens in new window) 01/12/2021 02:00 PM ET. 39th Annual JP Morgan Healthcare Conference. Webcast (opens in newwindow)
ALCON - INVESTOR RELATIONS Alcon is the world leader in eye care, dedicated to helping people see brilliantly. With our 70-plus-year heritage, we are the largest eye care device company in the world – with complementary businesses in Surgical and Vision Care. ALCON OFFICIAL SITE: DEVELOPING INNOVATIVE EYE CAREINNOVATIONCONTACT USCAREER SEARCHABOUT USINVESTOR RELATIONSMEDIA RELEASES At Alcon, we are proudly committed to creating a work culture that welcomes and celebrates diversity and inclusion. That’s why we are thrilled Alcon has earned a 95 percent rating on the Human Rights Campaign’s 2021 Corporate Equality Index.. Now in its 19th year, the Human Rights Campaign’s annual survey examines corporate policies and practices related to workplace equality for lesbianALCON: CAREERS
Alcon is an Equal Opportunity Employer and participates in E-Verify. Alcon takes pride in maintaining a diverse environment and our policies are not to discriminate in recruitment, hiring, training, promotion or other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, gender identity, marital or veteran status, disability, or any other CORPORATE SOCIAL RESPONSIBILITY Corporate Responsibility Report. Alcon has been actively engaged in environmental, social and governance (ESG) initiatives during our 70+ years in ophthalmology and optometry. In publishing our first Corporate Responsibility Report as an independent, standalone company, we are sharing our perspective on corporate citizenship anddemonstrating
RESPONSIBLE BUSINESS PRACTICE The Alcon Ethics Helpline is an independently managed, confidential online and telephone service available 24 hours a day, 7 days a week, in multiple languages. Concerns may be reported anonymously through the Helpline, where allowed under local law. For details about how to report, visit Alcon.Ethicspoint.com.ALCON
Convert K-readings to initial recommendation for our soft lensproducts. Content:
ALCON - NEWS AND EVENTS - EVENTS & PRESENTATIONS Alcon’s Fourth Quarter and Full Year 2020 Earnings Conference Call. Webcast (opens in new window) Earnings Release (opens in new window) Form 20-F (opens in new window) Regulatory Filing (opens in new window) Presentation (opens in new window) 01/12/2021 02:00 PM ET. 39th Annual JP Morgan Healthcare Conference. Webcast (opens in newwindow)
ALCON - INVESTOR RELATIONS Alcon is the world leader in eye care, dedicated to helping people see brilliantly. With our 70-plus-year heritage, we are the largest eye care device company in the world – with complementary businesses in Surgical and Vision Care. ALCON ANNOUNCES LAUNCH OF ACRYSOF IQ VIVITY, THE FIRST AND Vivity is a first-of-its-kind, non-diffractive extended depth of focus IOL with Alcon’s proprietary non-diffractive X-WAVE™ technology, which stretches and shifts light without splitting it. 1 Vivity delivers monofocal-quality distance (far) with excellent intermediate (at arm’s length) and functional near vision (up close). *2 The lens expands Alcon’s growing portfolio of presbyopia ALCON - FINANCIALS - ANNUAL REPORTS Alcon is incorporated outside the U.S. and qualifies as a foreign private issuer, or FPI. As long as we qualify as an FPI, we will be exempt from certain provisions of the Securities Exchange Act of 1934 that are applicable to U.S. domestic public companies, including: regulations governing the solicitation of proxies; consents or authorizations in respect of registered securities ALCON - ALCON FILES FINAL 20F To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. ALCON TO SHOWCASE VISION CARE INNOVATION, INCLUDING .q4default .bwlistdecimal { list-style-type: decimal }.q4default .bwlistdisc { list-style-type: disc }.q4default .bwuline { text-decoration: underline } 18 abstracts accepted, underscoring Alcon’s commitment to vision, comfort and ocular surface health TOTAL30 designed with water gradient technology that has biomimetic properties that mimic the corneal surface and demonstrates TECHNICAL PRODUCT INFORMATION ACRYSERT® Delivery System MODEL SN6CWS Product Information ACRYSOF® Aspheric UV Absorbing ReSTOR +2.5 D Toric IOL ALCON RESEARCH INSTITUTE Alcon Research Institute. In 1981, Alcon set out to help support research in eye health and to expand the frontiers of vision sciences globally – from this concept Alcon Research Institute (ARI) was born. Since then, the ARI has had a significant impact on the study of ocular diseases and has become a bridge to building partnerships with ALCON ANNOUNCES LAUNCH OF ACRYSOF IQ VIVITY, THE FIRST AND Vivity is a first-of-its-kind, non-diffractive extended depth of focus IOL with Alcon’s proprietary non-diffractive X-WAVE™ technology, which stretches and shifts light without splitting it. 1 Vivity delivers monofocal-quality distance (far) with excellent intermediate (at arm’s length) and functional near vision (up close). *2 The lens expands Alcon’s growing portfolio of presbyopia ALCON - NEWS AND EVENTS - EVENTS & PRESENTATIONS Alcon’s Fourth Quarter and Full Year 2020 Earnings Conference Call. Webcast (opens in new window) Earnings Release (opens in new window) Form 20-F (opens in new window) Regulatory Filing (opens in new window) Presentation (opens in new window) 01/12/2021 02:00 PM ET. 39th Annual JP Morgan Healthcare Conference. Webcast (opens in newwindow)
ALCON - INVESTOR RELATIONS Alcon is the world leader in eye care, dedicated to helping people see brilliantly. With our 70-plus-year heritage, we are the largest eye care device company in the world – with complementary businesses in Surgical and Vision Care. JOB SEARCH | ALCON.COM Privacy Policy; Cookie Notice; Terms of Use; Investors; Site Map; California Resident? Do Not Sell My Personal Information ALCON FEATURES NEW TECHNOLOGY UPGRADES FOR THE ORA SYSTEM San Diego, California, April 14, 2015 – Alcon, the global leader in eye care, will introduce enhancements to both the ORA System ® and the VERION™ Image Guided System, providing improved capabilities and efficiency during both preoperative planning and intraoperative guidance during the cataract surgery procedure. The new VerifEye+™ Technology and VERION 2.6 software update will be ALCON - FINANCIALS - QUARTERLY RESULTS Alcon is incorporated outside the U.S. and qualifies as a foreign private issuer, or FPI. As long as we qualify as an FPI, we will be exempt from certain provisions of the Securities Exchange Act of 1934 that are applicable to U.S. domestic public companies, including: regulations governing the solicitation of proxies; consents or authorizations in respect of registered securitiesHOME | AU.ALCON.COM
See Brilliantly. We aspire to lead the world in innovating life-changing vision and eye care products because when people see brilliantly, they live brilliantly. lightshow. About Alcon. Careers. Corporate Responsibility. Please wait for your event to start. The event has now ended. 0:00 | 1:27 LIVE. Go to main content. Press Shift+? for keyboard-shortcuts.Alcon Company
Menu
Close
Location MyAlcon
Search
* Patients
*
Eye Care Professionals * Eye Care Professionals * U.S. COVID-19 Resource Center*
About Alcon
* About Alcon
* Our History
* Our Business Focus * Investor Relations* Media Releases
* Corporate Social Responsibility * Responsible Business Practices* Leadership
* Careers
*
Innovation
* Innovation
* Sight Matters
* Range of Products
* A Pipeline for the Future * Alcon Research Institute* Partnerships
Your browser does not support the video tag. We aspire to lead the world in innovating life-changing vision and eye care products because when people see brilliantly, they livebrilliantly
Alcon Publishes First Corporate Responsibility Report Learn more*
Sight
*
Innovation
*
Eye Health for Everyone GET A CAREER AT ALCON A job at Alcon offers an opportunity to change the world for thebetter.
Explore your opportunities.CAREERS AT ALCON
Contact us
* YouTube
See Brilliantly
* Privacy Policy
* Cookie Notice
* Terms of Use
* Investors
* Site Map
* California Resident? Do Not Sell My Personal InformationOUR USE OF COOKIES
We use cookies that are strictly necessary to make our site work. We would also like to set optional cookies for the purposes of improving site content, personalizing content, tailoring advertising to your interests, and measuring site usage. By clicking "Accept and Continue" you are agreeing to the use of these cookies. Alternately, you can customize the cookies by clicking on "Manage Cookie Settings". For more information on our use of cookies, please visit our Cookie Noticepage.
Accept & Continue
Accept & Continue
Manage Cookie SettingsDetails
Copyright © 2024 ArchiveBay.com. All rights reserved. Terms of Use | Privacy Policy | DMCA | 2021 | Feedback | Advertising | RSS 2.0